Literature DB >> 8253534

Effect of epidermal growth factor and transforming growth factor beta 1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines.

H Kawamata1, S Kameyama, L Nan, K Kawai, R Oyasu.   

Abstract

We established 5 rat bladder cell lines (MYU3L, MYU4, MYU6s, MYKU1L and MYP3). EGF stimulated DNA synthesis of all the cells in monolayer culture, regardless of the number of EGF receptors. In soft agar, only MYU3L formed colonies, and EGF enhanced their growth. However, EGF did not induce the other cells to grow in soft agar. In contrast, TGF-beta 1 inhibited the growth of the cells, but a tumorigenic cell and the cells which were established from large in vivo tumors were more resistant than the others to TGF-beta 1. We tested the effect of growth factors on the invasive potential of MYP3 cells (non-tumorigenic), MYU3L cells (tumorigenic/highly invasive but not metastatic) from newly established cell lines, and another metastatic cell line, LMC19. MYP3 expressed only a trace amount of 92-kDa gelatinase (MMP-9), whereas MYU3L expressed interstitial collagenase (MMP-1) and MMP-9, and LMC19 expressed 72-kDa gelatinase (MMP-2) and MMP-9. The release of MMP-2 in LMC19 was stimulated by TGF-beta 1, but EGF had no effect on the release of any MMPs in either type of cells. These observations suggest that EGF acted as a mitogen on all the cells tested, but did not enhance the malignant phenotype. Further, the loss of responsiveness to the suppressive effect of TGF-beta 1 may be an important step toward a malignant phenotype. Some of malignant tumors may utilize TGF-beta 1 for enhancing their invasive and metastatic potential.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253534     DOI: 10.1002/ijc.2910550616

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  Extracellular matrix degradation by metalloproteinases and central nervous system diseases.

Authors:  A Lukes; S Mun-Bryce; M Lukes; G A Rosenberg
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  Elevated hydrostatic pressure stimulates ATP release which mediates activation of the NLRP3 inflammasome via P2X4 in rat urothelial cells.

Authors:  Cody L Dunton; J Todd Purves; Francis M Hughes; Huixia Jin; Jiro Nagatomi
Journal:  Int Urol Nephrol       Date:  2018-08-11       Impact factor: 2.370

3.  Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities.

Authors:  K Hida; M Shindoh; M Yasuda; M Hanzawa; K Funaoka; T Kohgo; A Amemiya; Y Totsuka; K Yoshida; K Fujinaga
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

4.  Inhibition of TGF-beta receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase.

Authors:  Yubing Li; Kai Yang; Qiqi Mao; Xiangyi Zheng; Debo Kong; Liping Xie
Journal:  Int Urol Nephrol       Date:  2009-08-08       Impact factor: 2.370

5.  Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer.

Authors:  Diana Levett; Paul A Flecknell; Philip S Rudland; Roger Barraclough; David E Neal; J Kilian Mellon; Barry R Davies
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

6.  Transcriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.

Authors:  Kathryn A Bailey; Kathleen Wallace; Lisa Smeester; Sheau-Fung Thai; Douglas C Wolf; Stephen W Edwards; Rebecca C Fry
Journal:  J Can Res Updates       Date:  2012-08-21

7.  The potential repertoire of the innate immune system in the bladder: expression of pattern recognition receptors in the rat bladder and a rat urothelial cell line (MYP3 cells).

Authors:  Francis M Hughes; David P Turner; J Todd Purves
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

8.  Thiothymidine combined with UVA as a potential novel therapy for bladder cancer.

Authors:  S W Pridgeon; R Heer; G A Taylor; D R Newell; K O'Toole; M Robinson; Y-Z Xu; P Karran; A V Boddy
Journal:  Br J Cancer       Date:  2011-05-24       Impact factor: 7.640

9.  BOO induces fibrosis and EMT in urothelial cells which can be recapitulated in vitro through elevated storage and voiding pressure cycles.

Authors:  Cody L Dunton; J Todd Purves; Francis M Hughes; Jiro Nagatomi
Journal:  Int Urol Nephrol       Date:  2021-07-07       Impact factor: 2.266

10.  Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.

Authors:  J K Mellon; S Cook; P Chambers; D E Neal
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.